The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome inin vitrofertilization patients: a pilot study
- 20 November 2012
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 29 (3) , 201-204
Abstract
The aim of this study was to evaluate the effects of bromocriptine on vascular endothelial growth factor (VEGF) levels in serum, kidney function and ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Twenty-eight women were randomly divided into two groups and were administered daily oral capsules for 14 days, starting on the day of human chorionic gonadotropin (hCG) administration. Group A received 2.0 mg of folic acid, whereas Group B was given 2.5 mg of bromocriptine. Physical exams, pelvic ultrasounds and laboratory evaluations were performed on the day of hCG administration and again 7 days later. No differences in ovarian hyperstimulation syndrome, urine volume, creatinine clearance, urine sodium concentration or serum VEGF levels were found between the two groups. Thus, these results indicate that bromocriptine does not affect blood levels of VEGF, kidney function or the incidence of ovarian hyperstimulation syndrome in high-risk patients subjected to in vitro fertilization.Keywords
This publication has 18 references indexed in Scilit:
- Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting: a new strategy to avoid ovarian hyperstimulation syndromeFertility and Sterility, 2011
- The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndromeFertility and Sterility, 2010
- Preventing ovarian hyperstimulation syndrome: guidance for the clinicianFertility and Sterility, 2010
- GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind studyReproductive BioMedicine Online, 2009
- Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized studyReproductive BioMedicine Online, 2008
- Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted ReproductionThe Journal of Clinical Endocrinology & Metabolism, 2007
- GnRH agonists vs antagonistsBest Practice & Research Clinical Obstetrics & Gynaecology, 2007
- Low-Dose Dopamine Agonist Administration Blocks Vascular Endothelial Growth Factor (VEGF)-Mediated Vascular Hyperpermeability without Altering VEGF Receptor 2-Dependent Luteal Angiogenesis in a Rat Ovarian Hyperstimulation ModelEndocrinology, 2006
- Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability1Biology of Reproduction, 2003
- Plasma levels of free vascular endothelial growth factor165 (VEGF165) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controlsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2001